$MOS

BMO Capital Adjusts Price Target on Mosaic Company to $31 From $35, Maintains Outperform Rating

BMO Capital has revised its price target for The Mosaic Company (MOS) to $31, down from $35, while reiterating an Outperform rating. This adjustment follows a trend of several other financial institutions also lowering their price targets for Mosaic, including Berenberg, Scotiabank, Barclays, Wells Fargo, UBS, and JPMorgan, indicating prevailing concerns across the analyst community. Despite the lowered target, BMO Capital's sustained "Outperform" rating suggests continued confidence in the company's performance potential.

Original reporting
Published May 21, 2026, 10:56 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 21, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$MOS
Neutral
medium confidence
Mentioned
$MOS · $BMO
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$MOSNeutralMed
01

Why it matters

Analyst revisions can impact investor sentiment and short-term trading volumes but are less indicative of long-term fundamentals.

02

Market read

The news is relevant primarily to investors and traders in the agricultural chemicals sector, with limited broader market impact.

03

What to watch

Potential upcoming earnings reports or sector developments could offset analyst concerns and influence stock performance.

Timing: short-term (next 1-4 weeks)

Background

The Mosaic Company is a leading producer of fertilizers and agricultural products, with its stock influenced by commodity prices and agricultural demand.

Company-level read

Ticker impact

$MOSNeutralMedium confidence
Context

The news pertains directly to Mosaic Company (MOS), affecting its valuation and investor sentiment.

Expected impact

Potential short-term decline in stock price due to lower target, but overall positive outlook maintained.

Evidence & confidence

The price target adjustment is based on analyst revisions, which may influence short-term trading but does not necessarily alter the company's fundamentals.

$BMONeutralHigh confidence
Context

BMO Capital's analyst revision influences investor perception of Mosaic, but BMO itself is not directly impacted.

Expected impact

No direct impact expected on BMO's stock.

Evidence & confidence

Analyst revisions are common and typically do not influence the bank's stock price unless accompanied by broader strategic changes.

Market effects

The fertilizer and agricultural chemicals sector may experience slight volatility due to analyst revisions affecting key players like Mosaic.

Limited; primarily affects North American investors and sectors.

Low; the news is sector-specific and does not significantly impact global markets.

Counterpoint

The reduction in price target may be an overreaction; Mosaic's fundamentals could support a rebound, making it a buying opportunity.

Key entities

  • The Mosaic Company

    A global leader in fertilizer production.

  • BMO Capital

    An investment bank providing analyst coverage.

Related articles

$MOSMed

S&P downgrades Mosaic outlook on high costs, weak cash flow

S&P Global Ratings downgraded Mosaic Co.’s outlook to negative from stable while keeping its BBB issuer credit rating. It expects funds from operations to debt below 20% in 2026. It projects adjusted EBITDA around $1.6B in 2026 vs $2.6B in 2025, citing high sulfur and ammonia costs, weaker phosphate margins, and negative discretionary cash flow of $400M to $500M.

$MOSLow

MOSAIC CO (MOS): Results of Operations and Financial Condition

MOSAIC CO (MOS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 performancedataq22026-ex992.htm EX-99.2 - PERFORMANCE DATA Document Exhibit 99.2 The Mosaic Company Selected Calendar Quarter Financial Information (Unaudited) Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Consolidated data (in millions, except per sha

$BMOMed

BMO earnings hit by severance, legal costs as it focuses on containing expenses - Investment Executive

BMO Financial Group reported Q3 profit of $1.45B, or $1.97 diluted EPS, up from $1.37B a year earlier, but adjusted EPS fell to $2.78 vs $3.09. Results were pressured by $223M severance, $83M legal provisions, higher credit-loss provisions ($492M), and a planned $45M impairment next quarter. Revenue rose to $7.93B on Bank of the West integration.

$BMOMedAI 8/10

BMO to shutter retail auto finance business as bad debt mounts - Investment Executive

BMO Financial Group will shut its indirect retail auto finance business, citing rising bad debts and a need to redeploy resources, according to the Bank of Montreal. The bank said quarterly bad debt provisions rose to $492 million for the quarter ended July 31, and retail credit-loss provisions rose to $81 million. Layoffs in Canada and the U.S. are expected.

$BMOMed

Corient (CI Financial subsidiary) will acquire Paris-based Letus Private Office, managing about US$5B in assets; terms weren’t disclosed

Corient (CI Financial subsidiary) will acquire Paris-based Letus Private Office, managing about US$5B in assets; terms weren’t disclosed. Corient said the deal would raise its total assets to US$523B. Other deals: BMO to buy Euroz Hartleys’ metals/mining unit; Empower to buy Millman’s retirement admin for US$340M; Nuvei to buy Payoneer for US$2.75B.

$BMOMed

Corient (CI Financial subsidiary) will acquire Paris-based Letus Private Office, managing about US$5B in assets; terms weren’t disclosed

Corient (CI Financial subsidiary) will acquire Paris-based Letus Private Office, managing about US$5B in assets; terms weren’t disclosed. Corient said the deal would raise its overall assets to US$523B. Other deals: BMO to buy Euroz Hartleys’ metals/mining unit; Empower to buy Millman for US$340M; Nuvei to buy Payoneer for $2.75B; Boralex to be acquired for $9.7B.